Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Materion
MTRN
$6.18B
| $10.8M | 0.01% |
145,909
+5,382
| +4% | +$432K |
|
|
WNS
327
DELISTED
WNS Holdings
WNS
| $10.7M | 0.01% |
143,721
+22
| +0% | +$1.68K |
|
328
Idexx Laboratories
IDXX
$46.1B
| $10.6M | 0.01% |
30,150
+493
| +2% | +$201K |
|
329
Synopsys
SNPS
$76.8B
| $10.5M | 0.01% |
34,476
+13
| +0% | +$3.92K |
|
330
PepsiCo
PEP
$189B
| $10.3M | 0.01% |
61,968
-9,434
| -13% | -$1.59M |
|
331
Steel Dynamics
STLD
$38.1B
| $10.1M | 0.01% |
152,673
-31,229
| -17% | -$2.5M |
|
332
Kimberly-Clark
KMB
$37.3B
| $9.75M | 0.01% |
72,116
-16,846
| -19% | -$2.22M |
|
333
LivePerson
LPSN
$26.1M
| $9.69M | 0.01% |
45,702
+38,073
| +499% | +$10.7M |
|
334
iShares 20+ Year Treasury Bond ETF
TLT
$41.8B
| $9.6M | 0.01% |
83,551
+66,436
| +388% | +$7.82M |
|
335
Factset
FDS
$9.88B
| $9.35M | 0.01% |
24,315
+8,555
| +54% | +$3.35M |
|
336
UFP Industries
UFPI
$5.24B
| $9.23M | 0.01% |
135,517
+19,442
| +17% | +$1.47M |
|
337
PTC Therapeutics
PTCT
$5.78B
| $9.11M | 0.01% |
227,297
+12,323
| +6% | +$432K |
|
338
Cactus
WHD
$5.28B
| $9.04M | 0.01% |
224,550
-6,629
| -3% | -$333K |
|
339
ACI Worldwide
ACIW
$5.88B
| $8.81M | 0.01% |
340,221
+31,334
| +10% | +$842K |
|
|
AYX
340
DELISTED
Alteryx Inc
AYX
| $8.73M | 0.01% |
180,218
+3,029
| +2% | +$181K |
|
341
XP
XP
$8.77B
| $8.67M | 0.01% |
482,491
+5,271
| +1% | +$121K |
|
342
Workday
WDAY
$42.2B
| $8.55M | 0.01% |
61,269
+26,569
| +77% | +$4.83M |
|
343
Vanguard Morningstar Growth ETF
VUG
$229B
| $8.18M | 0.01% |
220,128
+81,072
| +58% | +$3.33M |
|
344
Independent Bank
INDB
$4.08B
| $8.14M | 0.01% |
102,518
+6,519
| +7% | +$518K |
|
345
Prologis
PLD
$131B
| $8.05M | 0.01% |
68,427
+2,768
| +4% | +$383K |
|
346
Campbell Soup
CPB
$6.87B
| $7.97M | 0.01% |
165,828
-21,667
| -12% | -$1.02M |
|
347
Revvity
RVTY
$12.8B
| $7.95M | 0.01% |
55,879
-4,470
| -7% | -$670K |
|
348
Ichor Holdings
ICHR
$2.29B
| $7.86M | 0.01% |
302,682
+76,682
| +34% | +$2.22M |
|
349
iShares MSCI France ETF
EWQ
$342M
| $7.75M | 0.01% |
258,101
-19,976
| -7% | -$656K |
|
|
NVTA
350
DELISTED
Invitae Corporation
NVTA
| $7.57M | 0.01% |
3,103,628
+1,570,834
| +102% | +$6.95M |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.